Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

WR 77913

Known as: WR-77913 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Pantethine and the amino phosphorothioate, WR-77913, protected lenses against increased light scattering and opacification during… Expand
1995
1995
The radioprotective drug S-3-amino-2-hydroxypropylphosphorothioic acid (WR-77913) has been tested as an inhibitor of radiation… Expand
1991
1991
Abstract— Photooxidation, whether initiated by an endogenous or exogenous sensitizer, is an important mechanism in light induced… Expand
1991
1991
Complications of radiotherapy in the treatment of retinal and choroidal neoplastic diseases include cataract formation, radiation… Expand
1991
1991
Abstract— —Radioprotective agents have been found to protect normal tissues during photodynamic therapy (PDT). We have… Expand
1990
1990
The response of mouse intestine to d(22 MeV) + Be neutrons, p(50.5 MeV) + Be neutrons, or 137Cs gamma-rays was examined using… Expand
1986
1986
Protection by WR-77913 against radiation-induced cataract formation in rats was observed following intraperitoneal (i.p… Expand
1986
1986
Radiation induced cataracts are models for studying mechanisms of lens opacification. WR-77913, S-3-(amino-2-hydroxypropyl… Expand
1982
1982
The toxicity and radiation protective effect obtained by intraperitoneal injection of WR-77913 have been investigated in BALB/c… Expand
1982
1982
Experiments have been carried out to compare the toxicity and radioprotective effect of sodium hydrogen-S-(3-amino-2… Expand